South Korea Antipsychotic Drugs Market Size & Outlook
Related Markets
South Korea antipsychotic drugs market highlights
- The South Korea antipsychotic drugs market generated a revenue of USD 363.4 million in 2024 and is expected to reach USD 719.0 million by 2033.
- The South Korea market is expected to grow at a CAGR of 8.2% from 2025 to 2033.
- In terms of segment, schizophrenia was the largest revenue generating disease in 2024.
- Bipolar Disorder is the most lucrative disease segment registering the fastest growth during the forecast period.
Antipsychotic drugs market data book summary
| Market revenue in 2024 | USD 363.4 million |
| Market revenue in 2033 | USD 719.0 million |
| Growth rate | 8.2% (CAGR from 2025 to 2033) |
| Largest segment | Schizophrenia |
| Fastest growing segment | Bipolar Disorder |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.1% of the global antipsychotic drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China antipsychotic drugs market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,340.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antipsychotic Drugs Market Scope
Antipsychotic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| H. Lundbeck A/S | View profile | - | - | - |
| Eli Lilly and Company | View profile | - | - | - |
| Teva Pharmaceutical Industries Ltd. | View profile | - | - | - |
| Bristol-Myers Squibb Company | View profile | - | - | - |
| Alkermes PLC | View profile | 2100 | 1 Burlington Road, Connaught House, Dublin, Ireland, D04 C5Y6 | https://www.alkermes.com |
| Sumitomo Pharma Co Ltd | View profile | 6250 | 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Japan, 541-0045 | https://www.sumitomo-pharma.com |
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| Otsuka Pharmaceutical | View profile | 251-500 | Tokyo, Tokyo, Japan, Asia | https://www.otsuka.co.jp/en/ |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
South Korea antipsychotic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antipsychotic drugs market will help companies and investors design strategic landscapes.
Schizophrenia was the largest segment with a revenue share of 40.95% in 2024. Horizon Databook has segmented the South Korea antipsychotic drugs market based on schizophrenia, bipolar disorder, unipolar depression, dementia covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Korea antipsychotic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea antipsychotic drugs market databook
-
Our clientele includes a mix of antipsychotic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea antipsychotic drugs market , including forecasts for subscribers. This country databook contains high-level insights into South Korea antipsychotic drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea antipsychotic drugs market size, by disease, 2021-2033 (US$M)
South Korea Antipsychotic Drugs Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
